Predicted to enable DNA-binding transcription activator activity, RNA polymerase II-specific; RNA polymerase II cis-regulatory region sequence-specific DNA binding activity; and chromatin binding activity. Predicted to be involved in cell differentiation and positive regulation of transcription by RNA polymerase II. Predicted to act upstream of or within cell migration; mesenchyme development; and positive regulation of blood vessel remodeling. Predicted to be part of ribonucleoprotein complex. Predicted to be active in nucleus. Biomarker of pulmonary venoocclusive disease. Human ortholog(s) of this gene implicated in myeloid leukemia. Orthologous to human ERG (ETS transcription factor ERG). [provided by Alliance of Genome Resources, Apr 2022]